In a study published today in Nature Medicine, researchers from the University of Oxford and the Muhimbili University of ...

In a study published in Nature Medicine, researchers from the University of Oxford and the Muhimbili University of Health and Allied Sciences (MUHAS) in Dar es Salaam, Tanzania have shown that a ...

The study, published in Nature Medicine, demonstrates that the Guardant360® test helps identify patients who may benefit from treatment and can identify alterations that predict resistance The study, ...

Here we conclude our discussion with David P. Carbone, MD, PhD, The Ohio State University, by addressing the importance of both advocacy for and education on biomarker testing in the lung cancer space ...

What if a single blood test could determine whether you had one of 14 types of cancer? That's the question posed by a study published in November in the journal Cancer. Conducted by researchers at the ...

The promise of scientific and medical innovation often comes with a downside: improvements in care benefit some people, but not all. Without concerted effort, that is exactly what could happen with ...

A scan that makes prostate cancer cells “glow” could halve the number of men needing invasive biopsies, research suggests.

A novel liquid biopsy technology is set to advance cancer diagnostics and monitoring by overcoming the long-standing challenge of simultaneously achieving high sensitivity, broad coverage, and simple ...

Australian scientists say it could also help reduce the risk of overdiagnosis by determining which cancers are low-risk and will never cause harm.

During the 6 month period of the study, 1432 duodenal biopsies were received where celiac disease was part of the differential specified in the pathology request. Less than one-third of these patients ...

DUBLIN--(BUSINESS WIRE)--The "Worldwide Market for Liquid Biopsy, 6th Edition" report has been added to ResearchAndMarkets.com's offering. Liquid biopsies have emerged as a minimally invasive ...

Barcelona-based testing service will advance cancer research and enable clinicians to personalize treatments more accurately and quickly for patients with late-stage cancer PALO ALTO, Calif. & ...